60 DEGREES PHARMACEUTICALS, INC. financial data

Symbol
SXTP, SXTPW on Nasdaq
Location
Washington, DC
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 288% % -28%
Quick Ratio 35% % 26%
Debt-to-equity 53% % 58%
Return On Equity -217% % -43%
Return On Assets -141% % -24%
Operating Margin -838% % 57%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4,230,448 shares 84%
Common Stock, Shares, Outstanding 4,104,469 shares 120%
Entity Public Float $2,700,000 USD -77%
Common Stock, Value, Issued $410 USD 120%
Weighted Average Number of Shares Outstanding, Basic 3,675,407 shares 652%
Weighted Average Number of Shares Outstanding, Diluted 3,675,407 shares 71%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $943,721 USD 92%
Cost of Revenue $779,090 USD 89%
Research and Development Expense $2,081,238 USD -53%
General and Administrative Expense $6,410,886 USD 25%
Operating Income (Loss) $7,906,269 USD 17%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $7,976,879 USD -0.31%
Income Tax Expense (Benefit) $1,312 USD 62%
Net Income (Loss) Attributable to Parent $7,971,636 USD -0.72%
Earnings Per Share, Basic 1 USD/shares 86%
Earnings Per Share, Diluted 0 USD/shares 77%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,115,779 USD 25%
Cash, Cash Equivalents, and Short-term Investments $4,115,779 USD
Accounts Receivable, after Allowance for Credit Loss, Current $674,036 USD 108%
Inventory, Net $527,004 USD 17%
Assets, Current $6,309,209 USD -8.4%
Property, Plant and Equipment, Net $227,752 USD 47%
Intangible Assets, Net (Excluding Goodwill) $152,383 USD -42%
Other Assets, Noncurrent $152,383 USD -59%
Assets $6,689,344 USD -9.9%
Liabilities, Current $2,197,394 USD 68%
Liabilities $2,342,386 USD 61%
Accumulated Other Comprehensive Income (Loss), Net of Tax $144,039 USD 3.5%
Retained Earnings (Accumulated Deficit) $46,454,556 USD -21%
Stockholders' Equity Attributable to Parent $4,430,220 USD -27%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4,346,958 USD -27%
Liabilities and Equity $6,689,344 USD -9.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,597,366 USD -40%
Net Cash Provided by (Used in) Financing Activities $1,696,899 USD -11%
Net Cash Provided by (Used in) Investing Activities $1,702,518 USD
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 4,104,469 shares 120%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,792,147 USD 138%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4,115,779 USD 25%
Deferred Tax Assets, Valuation Allowance $5,915,350 USD 92%
Deferred Tax Assets, Gross $5,984,119 USD 58%
Depreciation $18,013 USD 23%
Payments to Acquire Property, Plant, and Equipment $2,678 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $7,966,804 USD -1.4%
Property, Plant and Equipment, Gross $403,437 USD 35%
Operating Lease, Liability, Current $529,449 USD
Deferred Tax Assets, Operating Loss Carryforwards $4,191,575 USD 20%
Additional Paid in Capital $41,172,888 USD 18%
Amortization of Intangible Assets $41,648 USD 2.7%
Depreciation, Depletion and Amortization $33,604 USD 182%
Deferred Tax Assets, Net of Valuation Allowance $68,769 USD -90%
Share-based Payment Arrangement, Expense $406,021 USD -88%